➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
McKinsey
Dow

Last Updated: November 29, 2020

DrugPatentWatch Database Preview

Litigation Details for Barkan Wireless IP Holdings, L.P. v. Samsung Electronics Co., Ltd. (E.D. Tex. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Biologic Drugs cited in Barkan Wireless IP Holdings, L.P. v. Samsung Electronics Co., Ltd.
The biologic drug covered by the patent cited in this case is   Start Trial .

Details for Barkan Wireless IP Holdings, L.P. v. Samsung Electronics Co., Ltd. (E.D. Tex. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-12-05 71 Claim Construction Brief contents or delete the information therein.” Id. at 10:41– 44. Defendants contend base station hardware…one form of claimed tamper-proofing. See id. at 10:41–44 (“This black box can be tamper-free, including…tampering” with billing and pricing policies); id. at 10:41–44 (describing tamper-proofing to include “delet[…A U.S. Patent No. 8,014,284 Exhibit B U.S. Patent No. 8,559,312 Exhibit C U.S. Patent No. 9,392,638… ’638 patent, and refers 8 The Patents-in-Suit claim priority based on a Patent Cooperation External link to document
2018-12-21 80 information therein as discussed at 10:41-44 of the ’312 patent. Indeed, the statement that the “black…terms of U.S. Patent Nos. 8,014,284 (the “’284 patent”), 8,559,312 (the “’312 patent) and 9,392,6389,392,638 (the “’638 patent”) (collectively, the “Asserted Patents” or “Patents-in-Suit”). Specifically, I have…of the claims as well as the entire patent, including the patent specification and figures. I also understand…than the term “gateway” used in the ’284 patent and ’312 patent claims is used to avoid External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson
Moodys
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.